Proteus Digital Health
1
8M
1
0.05
1
1
- Areas of investment
Summary
In 2001 was created Proteus Digital Health, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Redwood City. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Proteus Digital Health, startups are often financed by Pathfinder, Jim Greer. The meaningful sponsors for the fund in investment in the same round are Lux Capital, Founders Fund, Data Collective DCVC. In the next rounds fund is usually obtained by Lux Capital, Founders Fund, Dolby Family Ventures.
The fund was created by Andrew Thompson, George Savage, Mark Zdeblick.
The top activity for fund was in 2014. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is generally included in less than 2 deals every year.
Among the most successful fund investment fields, there are Biotechnology, Life Science. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Vium For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.05
- Investments by industry
- Medical Device (1)
- Biotechnology (1)
- Life Science (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Vium | 29 Oct 2014 | Biotechnology, Medical Device, Life Science | Early Stage Venture | 8M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.